HIV drug falls short with FDA
- Share via
Pfizer Inc., the world’s biggest drug maker, failed to win U.S. approval for maraviroc, the first new type of medicine in a decade to treat HIV, the virus that causes AIDS.
Pfizer is working on changes the Food and Drug Administration sought on the product’s labeling, the company said Wednesday. Maraviroc is intended for patients who have failed to reduce their levels of HIV with other treatments. If approved, Maraviroc would be an alternative for thousands of Americans with drug-resistant forms of HIV.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
